Other functions - preclinical efficacy and intermediate endpoint biomarkers - contract orientation meeting with NCI, office of acquisitions
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,709
Award facts
- Opportunity
-
- N01CN2500278 Solicitation number
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Feb 27, 2012
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Dec 15, 2011
- Contract value 100% obligated
- $3,709.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,521 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $5,230 |
About this award
This federal contract award is for a delivery order under the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle. The contract was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to the University of Oklahoma (OU) Univ Of Oklahoma Health Sciences Center Division. The contract is for "OTHER FUNCTIONS - PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS - CONTRACT ORIENTATION MEETING WITH NCI, OFFICE OF ACQUISITIONS" with a ceiling value of $3,709.16. This contract does not have a set-aside designation. OU, as a prime contractor, has previously provided a range of medical research, healthcare, and education services to various federal agencies, and has also served as a subcontractor for federally funded research initiatives.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN26100001 worth?
The government has obligated $3,709 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201200013I, an indefinite delivery contract, on Preclinical Efficacy and Intermediate Endpoint Biomarkers.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award